Senior Director, Global Regulatory Affairs, Novo Nordisk
Novo Nordisk A/S
SØBORG, Denmark
Thomas is the Senior Director of Global Regulatory Affairs, Regulatory Science, Policy, and Intelligence at Novo Nordisk, responsible for devices, combination products, IVD and Digital Health. He has extensive experience regulating medical devices and combination products in Europe and the US, effectively balancing business goals with regulatory requirements.
As a former Director of Medical Devices at the Danish Medicines Agency and a member of the European Medical Device Coordination Group (MDCG), Thomas has collaborated with the public sector, MedTech industry, and patient organizations to ensure patient safety.
He has also been elected Chair of the Competent Authorities for Medical Devices (CAMD), gaining valuable experience in both national and international forums, including engagements with the EU Commission, EMA, Head of Medicines Agency (HMA), Notified Bodies, Competent Authorities, and patient organizations.
Thomas holds a master’s degree in political science from the University of Copenhagen and has pursued additional education in project management and leadership. He has nearly 20 years of practical management experience.
Currently, Thomas is a member of the EFPIA Medical Devices WG, ERAO group and member of the Board of Medtech Pharma Platform (MPP) and serves on the Programme Committee for DIA/RAPS Combination Products Summit 2027.
Friday, May 8, 2026
12:30 - 13:30 WEST